Otonomy Files For IPO

San Diego-based Otonomy, the biopharmaceuticals firm which is developing treatment of diseases and disorders of the ear, has filed for an IPO, saying in a filing that it is looking to raised $86.25M in an offering on the NASDAQ Global Market. Otonomy said it intends to list under the symbol OTIC. Otonomy's IPO is being underwritten by J.P. Morgan, BofA Merrill Lynch, Piper Jaffray, and Sanford C. Bernstein. Otonomy is venture backed by Avalon Ventures, OrbiMed, Novo A/S, TPG Biotechnology Partners, Domain Associates, Rivervest Venture Partners, and others.